Els Hubloux

Newton Biocapital Partners SPRL is an active manager which invests in companies located in Belgium, Netherlands, Germany, France and Japan. It participates in early stage and seed stage transactions and focuses on sectors such as Health Technology.

QBIC Venture Partners invests in companies located in Belgium. The firm targets companies operating in the fields of software, deeptech, healthtech and biotech industries. It provides financing for seed, early and later stage capital requirements. The firm also makes follow-on investments.

Capricorn Partners invests in companies located in Europe. The firm focuses on sectors such as digital, health and clean technologies. It participates in early and growth stage capital transactions.

Quest invests in both private and public equity throughout Europe, with a focus on the ICT and life sciences sectors. They favor countries including Belgium, the Netherlands, the UK and Germany. Their investment vehicle Quest for Growth is managed as a cross-over fund targeting late-stage unlisted companies as well as small- to mid-cap listed equity. Part of their assets is invested indirectly in venture and private equity funds. Quest follows a hands-off, growth-oriented investment approach which can be contrarian at times, and is driven by in-house fundamental research. They target companies with high-growth potential across a broad range of industrial sectors including biotechnology, healthcare, semiconductors, telecommunications, software, electronics, information technology and new materials.

Provides brokerage services

Operates as a preclinical-stage biotechnology company which focuses on the development of first-in-class dual MET and RAS pathway inhibitor for targeted cancer therapies